Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety Study of Baricitinib for Patients With Intracerebral Hemorrhage

NCT06737705 is registered in ClinicalTrials.gov with De-zhi Kang as lead sponsor.

NCT NCT06737705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06737705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety Study of Baricitinib for Patients With Intracerebral Hemorrhage
Lead sponsor
De-zhi Kang
Phase
Phase 2
Overall status
Completed
Start date
January 1, 2025
Completion date
August 18, 2025
Enrollment
110 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

intracerebral hemorrhage